Emergence of Clostridium difficile NAP1 in Latin America

被引：52
作者：
Quesada-Gomez, Carlos [1 ,2 ]
Rodriguez, Cesar [1 ,2 ]
del Mar Gamboa-Coronado, Maria [1 ,2 ]
Rodriguez-Cavallini, Evelyn [1 ,2 ]
Du, Tim [3 ]
Mulvey, Michael R. [3 ]
Villalobos-Zuniga, Manuel [4 ]
Boza-Cordero, Ricardo [4 ]
机构：
[1] Univ Costa Rica, Lab Invest Bacteriol Anaerobia, Fac Microbiol, San Jose, Costa Rica
[2] Univ Costa Rica, Ctr Invest Enfermedades Trop, Fac Microbiol, San Jose, Costa Rica
[3] Natl Microbiol Lab, Winnipeg, MB, Canada
[4] Hosp San Juan Dios, San Jose, Costa Rica
来源：
JOURNAL OF CLINICAL MICROBIOLOGY | 2010年 / 48卷 / 02期
关键词：
TOXIN; EPIDEMIC; STRAIN;
D O I：
10.1128/JCM.02196-09
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
引用
收藏
页码：669 / 670
页数：2
相关论文
共 10 条
  • [1] Characterization of a toxin A-negative, toxin B-positive strain of Clostridium difficile responsible for a nosocomial outbreak of Clostridium difficile-associated diarrhea
    Alfa, MJ
    Kabani, A
    Lyerly, D
    Moncrief, S
    Neville, LM
    Al-Barrak, A
    Harding, GKH
    Dyck, B
    Olekson, K
    Embil, JM
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2000, 38 (07) : 2706 - 2714
  • [2] Clinical and Laboratory Standards Institute, 2007, M11A7 CLIN LAB STAND, pM11
  • [3] IDENTIFICATION OF TOXIGENIC CLOSTRIDIUM-DIFFICILE BY THE POLYMERASE CHAIN-REACTION
    KATO, N
    OU, CY
    KATO, H
    BARTLEY, SL
    BROWN, VK
    DOWELL, VR
    UENO, K
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 1991, 29 (01) : 33 - 37
  • [4] An epidemic, toxin gene-variant strain of Clostridium difficile
    McDonald, LC
    Killgore, GE
    Thompson, A
    Owens, RC
    Kazakova, SV
    Sambol, SP
    Johnson, S
    Gerding, DN
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (23) : 2433 - 2441
  • [5] Musher DM, 2006, NEW ENGL J MED, V354, P1199
  • [6] Reassessment of Clostridium difficile susceptibility to metronidazole and vancomycin
    Peláez, T
    Alcalá, L
    Alonso, R
    Rodríguez-Créixems, M
    García-Lechuz, JM
    Bouza, E
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (06) : 1647 - 1650
  • [7] Clostridium difficile:: Emergence of hypervirulence and fluoroquinolone resistance
    Razavi, B.
    Apisarnthanarak, A.
    Mundy, L. M.
    [J]. INFECTION, 2007, 35 (05) : 300 - 307
  • [8] Possible Seasonality of Clostridium difficile in Retail Meat, Canada
    Rodriguez-Palacios, Alexander
    Reid-Smith, Richard J.
    Staempfli, Henry R.
    Daignault, Danielle
    Janecko, Nicol
    Avery, Brent P.
    Martin, Hayley
    Thomspon, Angela D.
    McDonald, L. Clifford
    Limbago, Brandi
    Weese, J. Scott
    [J]. EMERGING INFECTIOUS DISEASES, 2009, 15 (05) : 802 - 805
  • [9] Comparative analysis of Clostridium difficile clinical isolates belonging to different genetic lineages and time periods
    Spigaglia, P
    Mastrantonio, P
    [J]. JOURNAL OF MEDICAL MICROBIOLOGY, 2004, 53 (11) : 1129 - 1136
  • [10] Production of actin-specific ADP-ribosyltransferase (binary toxin) by strains of Clostridium difficile
    Stubbs, S
    Rupnik, M
    Gibert, M
    Brazier, J
    Duerden, B
    Popoff, M
    [J]. FEMS MICROBIOLOGY LETTERS, 2000, 186 (02) : 307 - 312
1